Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) stock went on a downward path that fall over -0.42% on Monday, amounting to a one-week price decrease of more than -1.81%. Over the last 12 months, MDRX stock dropped by -16.65%. The one-year MDRX stock forecast points to a potential downside of -0.28, with the average price target set at $12.15 per share. The average equity rating for MDRX stock is currently 2.50, trading closer to a bullish pattern in the stock market.
The market cap for MDRX stock reached $1.55 billion, with 162.53 million shares outstanding and 160.23 million shares in the current float. Compared to the average trading volume of 1.88M shares, MDRX reached a trading volume of 5183395 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Allscripts Healthcare Solutions Inc. (MDRX):
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDRX shares is $12.15 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDRX stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Allscripts Healthcare Solutions Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 26, 2019. While these analysts kept the previous recommendation, Deutsche Bank raised their target price to Hold. The new note on the price target was released on September 26, 2019, representing the official price target for Allscripts Healthcare Solutions Inc. stock.
The Average True Range (ATR) for Allscripts Healthcare Solutions Inc. is set at 0.26, with the Price to Sales ratio for MDRX stock in the period of the last 12 months amounting to 0.88. The Price to Book ratio for the last quarter was 1.24, with the Price to Cash per share for the same quarter was set at 0.80. Price to Free Cash Flow for MDRX in the course of the last twelve months was 702.57 with Quick ratio for the last quarter at 0.70.
Trading performance analysis for MDRX stock
Allscripts Healthcare Solutions Inc. (MDRX) fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.81. With this latest performance, MDRX shares dropped by -4.61% in over the last four-week period, additionally sinking by -16.87% over the last 6 months – not to mention a drop of -16.65% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDRX stock in for the last two-week period is set at 35.09, with the RSI for the last a single of trading hit 33.22, and the three-weeks RSI is set at 37.85 for Allscripts Healthcare Solutions Inc. (MDRX). The present Moving Average for the last 50 days of trading for this stock 10.29, while it was recorded at 9.56 for the last single week of trading, and 10.29 for the last 200 days.
Allscripts Healthcare Solutions Inc. (MDRX): A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Allscripts Healthcare Solutions Inc. (MDRX) shares currently have an operating margin of -1.18 and a Gross Margin at +39.87. Allscripts Healthcare Solutions Inc.’s Net Margin is presently recorded at -1.79.
Return on Total Capital for MDRX is now -0.77, given the latest momentum, and Return on Invested Capital for the company is -1.29. Return on Equity for this stock declined to -2.35, with Return on Assets sitting at -0.85. When it comes to the capital structure of this company, Allscripts Healthcare Solutions Inc. (MDRX) has a Total Debt to Total Equity ratio set at 43.15. Additionally, MDRX Total Debt to Total Capital is recorded at 30.14, with Total Debt to Total Assets ending up at 21.04. Long-Term Debt to Equity for the company is recorded at 41.80, with the Long-Term Debt to Total Capital now at 29.20.
Reflecting on the efficiency of the workforce at the company, Allscripts Healthcare Solutions Inc. (MDRX) managed to generate an average of -$3,305 per employee. Receivables Turnover for the company is 3.18 with a Total Asset Turnover recorded at a value of 0.47. Allscripts Healthcare Solutions Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.70.
Allscripts Healthcare Solutions Inc. (MDRX): An earnings per share (EPS) analysis
With the latest financial reports released by the company, Allscripts Healthcare Solutions Inc. posted 0.2/share EPS, while the average EPS was predicted by analysts to be reported at 0.21/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -4.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Allscripts Healthcare Solutions Inc. go to 8.60%.
An analysis of insider ownership at Allscripts Healthcare Solutions Inc. (MDRX)
There are presently around $1,695 million, in the hands of institutional investors. The top three institutional holders of MDRX stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 21,634,550, which is approximately -5.222% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 21,427,801 shares of the stock with an approximate value of $204.64 million in MDRX stocks shares; and VANGUARD GROUP INC, currently with $159.87 million in MDRX stock with ownership of nearly 1.314% of the company’s market capitalization.
Positions in Allscripts Healthcare Solutions Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 100 institutional holders increased their position in Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) by around 10,144,563 shares. Additionally, 112 investors decreased positions by around 13,817,918 shares, while 35 investors held positions by with 153,511,649 shares. The mentioned changes placed institutional holdings at 177,474,130 shares, according to the latest SEC report filing. MDRX stock had 23 new institutional investments in for a total of 1,831,748 shares, while 29 institutional investors sold positions of 5,530,669 shares during the same period.